Tweet

Adequan is the trade name polysulfated glycosaminoglycan by Novartis Animal Health US, Inc. Adequan is a water-based injectable currently approved for veterinary uses.  Its pharmacology is described as a “disease modifying osteoarthritis drug.” Adequan has been purposely developed to treat joint injuries of race horses.

In bodybuilding circles, many buy and use Adequan to treat joint traumas and to improve range of motion and flexion. Bodybuilders and athletes who buy and use Adequan experience frictionless gliding during intense trainings because of ideal amount of synovial fluids. If you have bleeding disorders, you are advised against buying Adequan as this may exacerbate the problem. Because Adequan is not approved for human use, it is best to consult a doctor first before you buy Adequan.